showed a trendp = 0.06
After adjustment for BMI, basal FNDC5 expression was positively associated with fasting insulin levels (p = 0.0326, Figure 4F ) and showed a trend towards positive association with HOMA-IR (p = 0.06).
After adjustment for BMI, basal FNDC5 expression was positively associated with fasting insulin levels (p = 0.0326, Figure 4F ) and showed a trend towards positive association with HOMA-IR (p = 0.06).
amygdala activity Finally a William's test comparing the size of the correlations between ACS and DLPFC reactivity with that between ACS and amygdala activity showed a trend to significance ( t = 1.53, df = 15, p = 0.06) suggesting individual differences in ACS were more strongly correlated with DLPFC than amygdala activity.
A further interesting finding is that the connectivity strength of RS1 (RS period before the task has started) showed a trend for a significant correlation with subsequent task performance (Pearson’s r = 0.43, p = 0.06, see also File S3 ).
Stronger Trop-2 immunostaining showed a trend towards significance for overall and progression-free survival (Figure 1B and 1C , p=0.06 and p=0.05, respectively).
There were no significant differences in seropositivity among males versus females; RR 1.08 (95% CI 0.58–2.01), P = 0.82, while having a link with schools (teachers or students) showed a trend to be associated with seropositivity RR 1.85 (95% CI 0.96–3.57), P = 0.06.
Diazepam-treated HAB mice showed a trend to a reduction in the number of vocalizing animals compared to vehicle-treated HAB mice ( χ 2 = 3.55, p = 0.06; Figure 3 A), with the number of emitted sonic calls significantly decreased ( U = 31.5, p < 0.05; Figure 3 B).
Carotenoids were not significantly related to risk of dementia or AD, except for plasma trans‐β‐carotene, which showed a trend to be related to a higher risk of dementia (hazard ratio [HR] per standard deviation [SD]: 1.09; 95% confidence interval [CI]: 1.00, 1.20; P = .06) and α‐carotene, which also trended toward a higher AD risk alone (HR per SD: 1.15; 95% CI: 1.02, 1.29; P = .02).
In Cox proportional hazards models, high biomarker levels showed a trend toward conferring a higher risk of “not getting off treatment” as compared to low biomarker levels (for Gal‐9, hazard ratio [HR] 0.32, P = 0.06; for TNFRII, HR 0.24, P = 0.08; for CXCL10, HR 0.39, P = 0.1; for Gal‐1, HR 0.41, P = 0.1).
Although gender did not reach the level of significant differences, when age is considered as a covariate, it showed a trend ( F (1,72) = 3.58, P < .06).
T-stage and oct4 and ALDH1 expression showed a trend ( P >0.06).
In BMs, a higher density of CD20 + B cells was significantly associated with improved outcomes (P=0.007), while a high density of CD8 + T cells showed a trend toward better OS (P=0.06) ( Figure 5A ).
After matching, FPDMM‐AML patients again showed a trend toward a favorable outcome, albeit without statistical significance ( p = 0.06) (Figure 5F ).
qPCR validation of selected differentially expressed miRNAs indicated that miR-29b correlated with weight loss ( R = 0.5; p = 0.03) and miR-424 showed a trend (R 0.4; p = 0.06). miR-195 was also related to weight loss ( R = 0.4; p = 0.08).
These results are indirectly expressed with respect to genotype; the comparison of the CT and TT patients showed a trend toward a similar level of triglyceride reduction (t = 1.889; p = 0.06) (Table 8 ).
The IAM group showed a drop in scores by the third visit (2 months) which showed a trend ( P = 0.060) but did not reach statistical significance.
Specifically, significant mating biases were found in 12 females (11 females: p<0.001; 1 female: p<0.02), two females showed a trend towards a mating bias (fs11: p = 0.06 and fs04: p = 0.08, respectively), and for only one female matings were distributed randomly across males (B index not significant; fs15: p>0.3).
Post-hoc analysis of these interactions using the Sidak method found that for daytime dysfunction, participants in the SHT group showed a trend of reduction from pre- to post-test ( p = 0.06), while the control group did not, with Cohen’s d of 0.15.
Contingency table analysis did not provide any evidence for an association between IDO gene expression in tumor specimens and three classical clinicopathological parameters, PSA, pT, and Gleason score, while IL-6 gene expression was associated with PSA ( p = 0.02) and showed a trend toward association with Gleason score ( p = 0.06) (Table 5 ).
The only solicited adverse event that showed a trend towards more common occurrence in vaccine recipients was rash (27% of vaccinees, 0% placebo recipients, p = 0.06).
HIF-1α only showed a trend towards higher expression in node positive patients (p = 0.06), although HIF-1α expression was only found in one node negative tumor.
Pre-DDAVP VWF showed a trend towards lower levels in excellent responders (Ag: P =0.06, Act: P =0.07).
Results of the AST reveal that Tg mice performed significantly better than Wt mice on the compound discrimination reversal (CDR) phase (p = 0.01) ( Figure 6 A); they also showed a trend for improved performance on the simple discrimination (SD) phase (p = 0.06) and on the intradimensional reversal (IDR) phase (p = 0.08) ( Figure 6 A).
Survival analysis showed a trend towards longer survival in IL6ST-expressing luminal A tumours ( p = 0.06) but not in other subtypes ( Table 1 ).
Patients in the TXA group showed a trend for prolonged need of mechanical ventilation (45.4 h ± 187.3 versus 25.6 h ± 128.0; P = 0.06.
Additionally, only O increased MAFBx and RPS26 60–90 min after the first exercise bout in T legs compared to UT ( P < 0.05) and showed a trend for increase with MuRF‐1 ( P = 0.06).